AAAAAA
Results:
1-22
|
Results: 22
Authors:
van Geel, PP
Pinto, YM
Zwinderman, AH
Henning, RH
van Boven, A
Jukema, JW
Bruschke, AVG
Kastelein, JJP
van Gilst, WH
Citation: Pp. Van Geel et al., Increased risk for ischaemic events is related to combined RAS polymorphism, HEART, 85(4), 2001, pp. 458-462
Authors:
Hoffmann, S
Krause, T
van Geel, PP
Willenbrock, R
Pagel, I
Pinto, YM
Buikema, H
van Gilst, WH
Lindschau, C
Paul, M
Inagami, T
Ganten, D
Urata, H
Citation: S. Hoffmann et al., Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy, J MOL MED-J, 79(10), 2001, pp. 601-608
Authors:
Rothermund, L
Pinto, YM
Vetter, R
Herfort, N
Kossmehl, P
Neumayer, HH
Paul, M
Kreutz, R
Citation: L. Rothermund et al., Effects of angiotensin II subtype 1 receptor blockade on cardiac fibrosis and sarcoplasmic reticulum Ca2+ handling in hypertensive transgenic rats overexpressing the Ren2 gene, J HYPERTENS, 19(8), 2001, pp. 1465-1472
Authors:
de Boer, RA
Henning, RH
Suurmeijer, AJH
Pinto, YM
Olthof, E
Kirkels, JH
van Gilst, WH
Crijns, HJGM
van Veldhuisen, DJ
Citation: Ra. De Boer et al., Early expression of natriuretic peptides and SERCA in mild heart failure -Association with severity of the disease, INT J CARD, 78(1), 2001, pp. 5-12
Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS study)
Authors:
Oosterga, M
Voors, AA
Pinto, YM
Buikema, H
Grandjean, JG
Kingma, JH
Crijns, JHGM
van Gilst, WH
Citation: M. Oosterga et al., Effects of quinapril on clinical outcome after coronary artery bypass grafting (The QUO VADIS study), AM J CARD, 87(5), 2001, pp. 542-546
Authors:
Oosterga, M
Voors, AA
Buikema, H
Pinto, YM
Haber, HE
Ebels, T
Morshuis, WJ
Kingma, JH
Crijns, HJGM
van Gilst, WH
Citation: M. Oosterga et al., Angiotensin II formation in human vasculature after chronic ACE inhibition: A prospective, randomized, placebo-controlled study, CARDIO DRUG, 14(1), 2000, pp. 55-60
Authors:
Pinto, YM
Bader, M
Pesquero, JB
Tschope, C
Scholtens, E
Van Gilst, WH
Buikema, H
Citation: Ym. Pinto et al., Increased kallikrein expression protects against cardiac ischemia, FASEB J, 14(13), 2000, pp. 1861-1863
Authors:
Pinto, YM
Pinto-Sietsma, SJ
Philipp, T
Engler, S
Kossmehl, P
Hocher, B
Marquardt, H
Sethmann, S
Lauster, RP
Merker, HJ
Paul, M
Citation: Ym. Pinto et al., Reduction in left ventricular messenger RNA for transforming growth factorbeta(1) attenuates left ventricular fibrosis and improves survival withoutlowering blood pressure in the hypertensive TGR(mRen2)27 rat, HYPERTENSIO, 36(5), 2000, pp. 747-754
Authors:
van Geel, PP
Pinto, YM
Voors, AA
Buikema, H
Oosterga, M
Crijns, HJGM
van Gilst, WH
Citation: Pp. Van Geel et al., Angiotensin II type 1 receptor A1166C gene polymorphism is associated withan increased response to angiotensin II in human arteries, HYPERTENSIO, 35(3), 2000, pp. 717-721
Authors:
Teisman, ACH
van Veldhuisen, DJ
Boomsma, F
de Kam, PJ
Tjeerdsma, G
Pinto, YM
de Zeeuw, D
van Gilst, WH
Citation: Ach. Teisman et al., Chronic beta-blocker treatment in patients with advanced heart failure - Effects on neurohormones, INT J CARD, 73(1), 2000, pp. 7-12
Authors:
Pinto, YM
Pals, G
Zijlstra, JG
Tulleken, JE
Citation: Ym. Pinto et al., Ehlers-Danlos syndrome type IV., N ENG J MED, 343(5), 2000, pp. 366-368
Authors:
Rothermund, L
Pinto, YM
Hocher, B
Vetter, R
Leggewie, S
Kossmehl, P
Orzechowski, HD
Kreutz, R
Paul, M
Citation: L. Rothermund et al., Cardiac endothelin system impairs left ventricular function in renin-dependent hypertension via decreased sarcoplasmic reticulum Ca2+ uptake, CIRCULATION, 102(13), 2000, pp. 1582-1588
Authors:
Pinto, YM
Kok, RA
Baulcombe, DC
Citation: Ym. Pinto et al., Resistance to rice yellow mottle virus (RYMV) in cultivated African rice varieties containing RYMV transgenes, NAT BIOTECH, 17(7), 1999, pp. 702-707
Authors:
Roks, AJM
van Geel, PP
Pinto, YM
Buikema, H
Henning, RH
de Zeeuw, D
van Gilst, WH
Citation: Ajm. Roks et al., Angiotensin-(1-7) is a modulator of the human renin-angiotensin system, HYPERTENSIO, 34(2), 1999, pp. 296-301
Authors:
Pinto, YM
van Geel, PP
Alkfaji, H
van Veldhuisen, DJ
van Gilst, WH
Citation: Ym. Pinto et al., Dosing of ACE inhibitors in left ventricular dysfunction: Does current clinical dosing provide optimal benefit?, J CARDIO PH, 34, 1999, pp. S13-S17
Authors:
Pinto, YM
van Gelder, IC
Crijns, HJGM
Heeringa, M
Citation: Ym. Pinto et al., Causality assessment of adverse drug effects: when is rechallenge ethically acceptable? Reply, LANCET, 354(9179), 1999, pp. 683-683
Authors:
Pinto, YM
van Gelder, IC
Heeringa, M
Crijns, HJGM
Citation: Ym. Pinto et al., QT lengthening and arrhythmias associated with fexofenadine - Reply, LANCET, 353(9169), 1999, pp. 2072-2073
Authors:
Pinto, YM
van Gelder, IC
Heeringa, M
Crijns, HJGM
Citation: Ym. Pinto et al., Qi lengthening and life-threatening arrhythmias associated with fexofenadine, LANCET, 353(9157), 1999, pp. 980-980
Authors:
Voinnet, O
Pinto, YM
Baulcombe, DC
Citation: O. Voinnet et al., Suppression of gene silencing: A general strategy used by diverse DNA and RNA viruses of plants, P NAS US, 96(24), 1999, pp. 14147-14152
Authors:
Pinto, YM
van Gilst, WH
Citation: Ym. Pinto et Wh. Van Gilst, The ACE gene polymorphism: the good, the bad and the ugly, CARDIO RES, 43(1), 1999, pp. 23-24
Authors:
van Veldhuisen, DJ
Genth-Zotz, S
Brouwer, J
Boomsma, F
Netzer, T
Man In't Veld, AJ
Pinto, YM
Lie, KI
Crijns, HJGM
Citation: Dj. Van Veldhuisen et al., High- versus low-dose ACE inhibition in chronic heart failure - A double-blind, placebo-controlled study of imidapril, J AM COL C, 32(7), 1998, pp. 1811-1818
Authors:
Teisman, ACH
Pinto, YM
Buikema, H
Flesch, M
Bohm, M
Paul, M
van Gilst, WH
Citation: Ach. Teisman et al., Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats, J HYPERTENS, 16(12), 1998, pp. 1759-1765
Risultati:
1-22
|